Related Experiment Videos

Reducing T cell activation as a therapy for human immunodeficiency virus infection

The Journal of Infectious Diseases

|March 1, 1995

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Enrichment of herpes simplex virus type 2 (HSV-2) reactive mucosal T cells in the human female genital tract.

Mucosal immunology·2017

A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial.

Vaccine·2016

Persistence of mucosal T-cell responses to herpes simplex virus type 2 in the female genital tract.

Mucosal immunology·2014

Are there benefits to starting antiretroviral therapy during primary HIV infection? Conclusions from the Seattle Primary Infection Cohort vary by control group.

International journal of STD & AIDS·2012

Safety and pharmacokinetics of aciclovir in women following release from a silicone elastomer vaginal ring.

The Journal of antimicrobial chemotherapy·2012

Early emergence of an H275Y mutation in a hematopoietic cell transplant recipient treated with intravenous peramivir.

Transplant infectious disease : an official journal of the Transplantation Society·2010

See all related articles